Can tiny heart vessel problems predict major cardiac events?
NCT ID NCT07293338
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how problems in the heart's tiny blood vessels (coronary microvascular dysfunction) affect long-term outcomes in people with dilated cardiomyopathy, a condition where the heart muscle is enlarged and weak. Researchers will follow 330 participants who have already had a heart catheterization to check for blocked arteries. The goal is to see if microvascular dysfunction is linked to serious events like heart failure hospitalization, heart transplant, or death.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict heart complications in people with dilated cardiomyopathy, leading to more personalized monitoring and treatment.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve patient outcomes. Results may not apply to all patients with dilated cardiomyopathy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DILATED CARDIOMYOPATHY (DCM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The second affiliated hospital of Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310009, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Second infusion of designer cells aims to rescue failing hearts
- New study tracks rare genetic heart condition
- One-Time gene infusion aims to repair hearts in rare genetic condition
- 5,000 heart patients to wear smart patches for Years-Long observation
- Experimental cell therapy targets End-Stage heart disease
- One-Time gene shot aims to mend broken hearts